Triumph Capital Management’s iShares MSCI Brazil ETF EWZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95K Sell
2,754
-59
-2% -$2.21K 0.02% 499
2026
Q1
$108K Sell
2,813
-73
-3% -$2.67K 0.02% 443
2025
Q4
$91.7K Buy
+2,886
New +$91.3K 0.02% 457
2024
Q3
Sell
-9,128
Closed -$249K 278
2024
Q2
$249K Sell
9,128
-896
-9% -$27.2K 0.1% 196
2024
Q1
$319K Sell
10,024
-930
-8% -$30.8K 0.13% 162
2023
Q4
$383K Sell
10,954
-910
-8% -$29.5K 0.16% 123
2023
Q3
$364K Buy
11,864
+1,431
+14% +$45.5K 0.17% 131
2023
Q2
$338K Sell
10,433
-24,206
-70% -$720K 0.15% 132
2023
Q1
$948K Buy
34,639
+13,136
+61% +$368K 0.48% 40
2022
Q4
$601K Buy
21,503
+10,598
+97% +$324K 0.32% 69
2022
Q3
$323K Buy
10,905
+763
+8% +$22.5K 0.18% 121
2022
Q2
$278K Buy
+10,142
New +$336K 0.15% 151

Other funds holding EWZ

Triumph Capital Management's EWZ Position: Q2 2026 in Review

Triumph Capital Management reduced its iShares MSCI Brazil ETF (EWZ) stake by 2.1% in Q2 2026, selling an estimated $2.21K and leaving 2,754 shares worth $95K. The position accounts for 0.02% of the portfolio, ranked #499.

Triumph Capital Management first reported a position in EWZ in Q2 2022 and has held it in 12 quarters since. The position peaked at $948K in Q1 2023. 403 funds tracked by Wall St. Rank hold EWZ as of Q2 2026.

  • Triumph Capital Management held 2,754 shares of iShares MSCI Brazil ETF worth $95K as of Q2 2026.
  • Triumph Capital Management sold 59 iShares MSCI Brazil ETF shares in Q2 2026, an estimated $2.21K.
  • iShares MSCI Brazil ETF made up 0.02% of Triumph Capital Management's portfolio in Q2 2026, its #499 holding.
  • Triumph Capital Management first reported a position in iShares MSCI Brazil ETF in Q2 2022 and has held it in 12 quarters since.
  • Triumph Capital Management's iShares MSCI Brazil ETF position peaked at $948K in Q1 2023.
  • 403 funds tracked by Wall St. Rank held iShares MSCI Brazil ETF as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.